Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 258-270

  Swerdlow, Charles D ^a,b   Shehata, Michael ^a   Chen, Peng Sheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Defibrillation; Defibrillation testing; Defibrillation threshold; Implantable cardioverter defibrillator; T wave shock; Upper limit of vulnerability

Indexed keywords

ACCURACY; CLINICAL RESEARCH; DEFIBRILLATION; DEFIBRILLATOR; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTHESIS; IMPLANT; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS; SYNCOPE; T WAVE;

ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; ELECTRIC COUNTERSHOCK; HUMANS; PROGNOSIS; THERAPY, COMPUTER-ASSISTED; VENTRICULAR FIBRILLATION;

EID: 33847372957     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00659.x     Document Type: Review

References (90)

1. Fabiato PA, Coumel P, Gourgon R, Saumont R. Le seuil de réponse synchrone des fibres myocardiques. Application à la comparaison expérimentale de l'efficacité des différentes formes de chocs électriques de défibrillation. Arch des Mal du Coeur 1967; 60:527-544.
2. Ferris LP, King BG, Spence PW, Williams HB. Effect of electric shock on the heart. Electr Eng 1936; 55:498-515.
3. Chen P-S, Shibata N, Dixon E, Martin R, Ideker R. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986; 73:1022-1028.
4. Winfree AT. Sudden cardia death: A problem in topology. Sci Am 1983; 248:144-149.
5. Fabritz CL, Kirchhof PF, Behrens S, Zabel M, Franz MR. Myocardial vulnerability to T wave shocks: Relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization. J Cardiovasc Electrophysiol 1996; 7(3):231-242.
6. King B. The effect of electric shock on heart action with special reference to varying susceptibility in different parts of the cardiac cycle (PhD Thesis), Columbia University, New York; 1934.
7. Battelli F. Le mécanisme de la mort par les courants électriques chez l'homme. Revue Med Suisse Romande 1899; 10:605-618.
8. Shibata N, Chen P-S, Dixon EG, Wolf PD, Danieley ND, Smith WM, Ideker RE. Influence of epicardial shock strength and timing on the induction of ventricular arrhythmias in dogs. Am J Physiol 1988; 255:H891-H901.
9. Smith W, Funk A, Ideker R, Bartram F, Talbert P. A microcomputer-based multichannel data acquisition system for the study of complex arrhythmias. Comput Cardiol 1982:131-134.
10. Zhou X, Daubert JP, Wolf PD, Smith WM, Ideker RE. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res 1993; 72(1):145-160.
11. Efimov IR, Cheng Y, Van Wagoner DR, Mazgalev T, Tchou PJ. Virtual electrode-induced phase singularity: A basic mechanism of defibrillation failure. Circ Res 1998; 82(8):918-925.
12. Yamanouchi Y, Cheng Y, Tchou PJ, Efimov IR. The mechanisms of the vulnerable window: The role of virtual electrodes and shock polarity. Can J Physiol Pharmacol 2001; 79(1):25-33.
13. Efimov IR, Gray RA, Roth BJ. Virtual electrodes and deexcitation: New insights into fibrillation induction and defibrillation. J Cardiovasc Electrophysiol 2000; 11(3):339-353.
14. Fabritz C, Kirchoff P, Behrens S, Zabel M, Franz M. Myocardial vulnerability to T wave shocks: Relation to shock strength, shock coupling interval, and dispersion of repolarization. J Cardiovasc Electrophysiol 1996; 7:231-242.
15. Lesigne C, Levy B, Saumont R, Birkui P, Bardou A, Rubin B. An energy-time analysis of ventricular fibrillation and defibrillation thresholds with internal electrodes. Med Biol Eng 1976; 14:617-622.
16. Swerdlow C, Martin D, Kass R, Davie S, Mandel W, Gang E, Chen P. The zone of vulnerability to T-wave shocks in humans. J Cardiovasc Electrophysiol 1997; 8:145-154.
17. Chen P-S, Shibata N, Dixon EG, Wolf PD, Danieley ND, Sweeney MB, Smith WM, et al. Activation during ventricular defibrillation in open-chest dogs. J Clin Invest 1986; 77:810-823.
18. Chen P-S, Shibata N, Wolf P. Epicardial activation during successful and unsuccessful ventricular defibrillation in open chest dogs. Cardiovas Rev Rep 1986; 7:625-648.
19. Chen P-S, Wolf PD, Ideker RE. The mechanism of cardiac defibrillation: A different point of view. Circulation 1991; 84:913-919.
20. Chen P-S, Wolf PD, Melnick SD, Danieley ND, Smith WM, Ideker RE. Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open chest dogs. Circ Res 1990; 66:1544-1560.
21. Chen PS, Shibata N, Dixon EG, Martin RO, Ideker RE. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. irculation. May 1986; 73(5):1022-1028.
22. Malkin RA, Idriss SF, Walker RG, Ideker RE. Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves. Circulation 1995; 92(5):1291-1299.
23. Bessho R, Tanaka S. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement. Int J Artif Organs. 1998; 21(3):151-160.
24. Birgersdotter-Green U, Undesser K, Fujimura O, Feld GK, Kass RM, Mandel WJ, Peter CT, et al. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm. J Interv Card Electrophysiol 1999; 3(2):155-161.
25. Chen P-S, Feld GK, Kriett JM, Mower MM, Tarazi RY, Fleck RP, Swerdlow CD, et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993; 88:186-192.
26. Hui RC, Rosenthal L, Ramza B, Nsah E, Lawrence J, Tomaselli G, Berger R, et al. Relationship between the upper limit of vulnerability determined in normal sinus rhythm and the defibrillation threshold in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1998; 21(4 Pt 1):687-693.
27. Hwang C, Swerdlow CD, Kass RM, Gang ES, Mandel WJ, Peter CT, Chen PS. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994; 90(5):2308-2314.
28. Kirilmaz A, Dokumaci B, Uzun M, Kilicaslan F, Dinckal MH, Yucel O, Karaca M. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation. Pacing Clin Electrophysiol 2005; 28(6):498-505.
29. Fan W, Gotoh M, Chen PS. Effects of the pacing site, procainamide, and lead configuration on the relationship between the upper limit of vulnerability and the defibrillation threshold. Pacing Clin Electrophysiol 1995; 18(6):1279-1284.
30. Idriss SF, Wolf PD, Smith WM, Ideker RE. Effect of pacing site on ventricular fibrillation initiation by shocks during the vulnerable period. Am J Physiol 1999; 277(5 Pt 2):H2065-2082.
31. Huang J, KenKnight BH, Walcott GP, Rollins DL, Smith WM, Ideker RE. Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability. Circulation 1997; 96(4):1351-1359.
32. Swerdlow CD, Kass RM, O'Connor ME, Chen PS. Effect of shock waveform on relationship between upper limit of vulnerability and defibrillation threshold. J Cardiovasc Electrophysiol 1998; 9(4):339-349.
33. Shorofsky SR, Rashba E, Havel W, Belk P, Degroot P, Swerdlow C, Gold MR. Improved defibrillation efficacy with an ascending ramp waveform in humans. Heart Rhythm 2005; 2(4):388-394.
34. Behrens S, Li C, Franz MR. Effects of myocardial ischemia on ventricular fibrillation inducibility and defibrillation efficacy. J Am Coll Cardiol 1997; 29(4):817-824.
35. Martin D, Hwnag C, Gang E, Mandel W, Peter C, Swerdlow C. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous defibrillators. J Cardiovasc Electophysiol 1997; 8:241-248.
36. Kwaku KF, Dillon SM. Shock-induced depolarization of refractory myocardium prevents wave-front propagation in defibrillation. Circ Res 1996; 79(5):957-973.
37. Dillon SM, Kwaku KF. Progressive depolarization: A unified hypothesis for defibrillation and fibrillation induction by shocks. J Cardiovasc Electrophysiol 1998; 9(5):529-552.
38. Fast V. Cellular mechanisms of defibrillation. In: Zipes D, Jalife J (eds.): Cardiac Electrophysiology: From Cell to Bedside. 4th Ed. Philadelphia, Saunders, 2004, pp. 407-416.
39. Gray R. Global mechanisms of defibrillation. In: Zipes D, Jalife J, (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Saunders, 2004, pp. 417-425.
40. Shibata N, Chen P-S, Dixon EG, Wolf PD, Danieley ND, Smith WM, Ideker RE. Epicardial activation following unsuccessful defibrillation shocks in dogs. Am J Physiol 1988; 255:H902-909.
41. Efimov I, Ripplinger C. Virtual electrode hypothesis of defibrillation. Heart Rhythm 2006; 3:in press.
42. Efimov IR, Cheng Y, Yamanouchi Y, Tchou PJ. Direct evidence of the role of virtual electrode-induced phase singularity in success and failure of defibrillation. J Cardiovasc Electrophysiol 2000; 11(8):861-868.
43. Evans FG, Ideker RE, Gray RA. Effect of shock-induced changes in transmembrane potential on reentrant waves and outcome during cardioversion of isolated rabbit hearts. J Cardiovasc Electrophysiol 2002; 13(11):1118-1127.
44. Chattipakorn N, Banville I, Gray RA, Ideker RE. Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: A whole-heart optical mapping study in swine. Circulation 2001; 104(11):1313-1319.
45. Chattipakorn N, Fotuhi PC, Chattipakorn SC, Ideker RE. Three-dimensional mapping of earliest activation after near-threshold ventricular defibrillation shocks. J Cardiovasc Electrophysiol 2003; 14(1):65-69.
46. Thomas SP, Thiagalingam A, Wallace E, Kovoor P, Ross DL. Organization of myocardial activation during ventricular fibrillation after myocardial infarction: Evidence for sustained high-frequency sources. Circulation 2005; 112(2):157-163.
47. Swerdlow C, Shivkumar K, Zhang J. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms. Circulation 2003; 107(24):3028-3033.
48. Swerdlow CD, Martin DJ, Kass RM, Davie S, Mandel WJ, Gang ES, Chen PS. The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol 1997; 8(2):145-154.
49. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998; 98(18):1928-1936.
50. Chen PS, Feld GK, Kriett JM, Mower MM, Tarazi RY, Fleck RP, Swerdlow CD, et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993; 88(1):186-192.
51. Chen PS, Feld GK, Mower MM, Peters BB. Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol 1991; 18(6):1555-1563.
52. Souza JJ, Malkin RA, Ideker RE. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system. Circulation 1995;91(4):1247-1252.
53. Lemke B, Calcum B, von Dryander S, Jager D, Lawo T, Machraoui A, Barmeyer J. Judgment on the probability for defibrillation based on the "upper limit of vulnerability." Pacing Clin Electrophysiol 1995; 18:947.
54. Swerdlow CD, Ahern T, Kass RM, Davie S, Mandel WJ, Chen PS. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol 1996; 27(5):1112-1118.
55. Swerdlow C, Ahern T, Chen P-S. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability. Pacing Clin Electrophysiol 1996; 19:2103-2111.
56. Day J, Doshi R, Belott P. Most patients may safely undergo inductionless or limited shock testing at ICD implantation (abstract). Heart Rhythm 2005; 2:S232.
57. Martin DJ, Chen PS, Hwang C, Gang ES, Mandel WJ, Peter CT, Swerdlow CD. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators. J Cardiovasc Electrophysiol 1997;8(3):241-248.
58. Swerdlow C, Peter C, Hwang C, Kass R, Mandel W, Gang E, Chen P. Programming of implantable defibrillators based on the upper limit of vulnerability rather than the defibrillation threshold. Circulation 1997; 95:1497-1504.
59. Cha YM, Peters BB, Chen PS. Use-dependent effects of lidocaine on the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol 1994; 23(7):1688-1692.
60. Gurevitz OT, Friedman PA, Glikson M, Trusty JM, Ballman KV, Rosales AG, Hayes DL, et al. Discrepancies between the upper limit of vulnerability and defibrillation threshold: Prevalence and clinical predictors. J Cardiovasc Electrophysiol 2003; 14(7):728-732.
61. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001; 103(17):2159-2164.
62. Green UB, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. J Interv Card Electrophysiol 2003; 8(1):71-75.
63. Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol 1992; 70(11):1017-1022.
64. Glikson M, Luria D, Friedman PA, Trusty JM, Benderly M, Hammill SC, Stanton MS. Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol 2000; 11(2):127-135.
65. Panotopoulos P, Krum D, Axtell K, Dhala A, Sra J, Akhtar M, Deshpande S. Ventricular fibrillation sensing and detection by implantable defibrillators: Is one better than the others?Aprospective, comparative study. J Cardiovasc Electrophysiol 2001; 12(4):445-452.
66. Dekker LR, Schrama TA, Steinmetz FH, Tukkie R. Undersensing of VF in a patient with optimal R wave sensing during sinus rhythm. Pacing Clin Electrophysiol 2004; 27(6 Pt 1):833-834.
67. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: Part II. Pacing Clin Electrophysiol 2006; 29(1):70-96.
68. Taneja T, Goldberger J, Parker MA, Johnson D, Robinson N, Horvath G, Kadish AH. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol 1997; 8(11):1209-1217.
69. DeGroot P, Swerdlow C. Upper limit of vulnerability is a more efficient research method for comparing defibrillation efficacy than defibrillation threshold. (abstract) Pacing Clin Electrophysiol 1998; 21:931.
70. Malkin R. Estimating defibrillation efficacy using upper limit of vulnerability testing (PhD Thesis), Duke University, 1993.
71. Lemke B, Lubinski J, Mueller J. Defibrillation threshold based on the upper limit of vulnerability. (abstract) Europace 2004; 6:54/55.
72. Atunes M, Spotnitz H, Livelli F, Steinberg J, Bigger J. Effect of electrophysiological testing on ejection fraction during cardioverter/ defibrillator implantation. Ann Thorac Surg 1988; 45(3):315-318.
73. Meesman M. Factors associated with implantation-related complications. Pacing Clin Electrophysiol 1992; 15:649-653.
74. Vlay SC. Defibrillation threshold testing: Necessary but evil? Am Heart J 1989; 117(2):499-504.
75. Singer I, Edmonds H, Jr. Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. Am Heart J 1994; 127(4 Pt 2):1052-1057.
76. Singer I, Lang D. Defibrillation threshold: Clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992; 15:932-949.
77. de Vries JW, Bakker PF, Visser GH, Diephuis JC, van Huffelen AC. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing. Anesth Analg 1998; 87(1):16-20.
78. Vriens EM, Bakker PF, Vries JW, Wieneke GH, Van Huffelen AC. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. Electroencephalogr Clin Neurophysiol 1996; 98(4):236-242.
79. Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K, Hollinger I, et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 1992; 15(6):870-877.
80. Tokano T, Bach D, Chang J, Davis J, Souza JJ, Zivin A, Knight BP, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998; 9(8):791-797.
81. Neuzner J, Liebrich A, Jung J, Himmrich E, Pitschner HF, Winter J, Vester EG, et al. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented stepdown defibrillation threshold: Results of the prospective, randomized, multicenter Low-Energy Endotak Trial. Am J Cardiol 1999; 83(5B):34D-39D.
82. Day J, Freedman R, Zubair I. Most patients may safely undergo inductionless ICD implants. (abstract) Circulation 2003.
83. Swartz J, Karasik P, Bacon M, Fletcher R. Relationship of upper limit of vulnerability to defibrillation threshold for monophasic and biphasic waveform human nonthoracotomy defibrillation. (abstract) J Am Coll Cardiol 1994; 23:293A.
84. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Effects of interventions that alter repolarization time. Circulation 1990; 81(1):281-288.
85. Millar CK, Kralios FA, Lux RL. Correlation between refractory periods and activation-recovery intervals from electrograms: Effects of rate and adrenergic interventions. Circulation 1985; 72(6):1372-1379.
86. Wyatt R. Comparison of estimates of activation and recovery times from bipolar and unipolar electrograms to in vivo transmembrane action potential duration. Paper presented at: Proceedings IEE: Engineering Medical Biologists Society Second Annual Conference, 1980, Washington DC.
87. Taggart P, Sutton PM, Opthof T, Coronel R, Trimlett R, Pugsley W, Kallis P. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res 2001; 50(3):454-462.
88. Chen PS, Moser KM, Dembitsky WP, Auger WR, Daily PO, Calisi CM, Jamieson SW, et al. Epicardial activation and repolarization patterns in patients with right ventricular hypertrophy. Circulation 1991; 83(1):104-118.
89. Chinushi M, Tagawa M, Kasai H, Washizuka T, Abe A, Furushima H, Aizawa Y. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment. Jpn Circ J 2001; 65(8):702-706.
90. Swerdlow CD, Davie S, Ahern T, Chen PS. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability. Pacing Clin Electrophysiol 1996; 19(12 Pt 1):2103-2111.